ACTU

Actuate Therapeutics Inc

There isn't enough reported data to score ACTU yet.

ACTU Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

ACTU's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

ACTU PE Valuation

ACTU has no meaningful PE right now: it lost money over the past year.

ACTU Forward outlook

MetricOutlook
--
Losses shrinking
--
--
Limited
Low

Analysts expect ACTU's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.

ACTU Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.30 on Nov 12.

There is not enough scenario data to assess ACTU's risk to reward.

ACTU Earnings Per Share

Q4 2025: $-1.06Q1 2026: $-0.98Q2 2026: $-0.88
Q4 2025: $-1.06Q1 2026: $-0.98Q2 2026: $-0.88

ACTU Quarterly Revenue

Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

ACTU Free Cash Flow

Q3 2023: −$6MQ4 2023: −$6MQ1 2024: −$5MQ2 2024: --Q3 2024: −$9MQ4 2024: −$5MQ1 2025: −$5MQ2 2025: −$4MQ3 2025: −$7MQ4 2025: −$4MQ1 2026: −$5MQ2 2026: −$4M
Q3 2023: −$6MQ4 2023: −$6MQ1 2024: −$5MQ2 2024: --Q3 2024: −$9MQ4 2024: −$5MQ1 2025: −$5MQ2 2025: −$4MQ3 2025: −$7MQ4 2025: −$4MQ1 2026: −$5MQ2 2026: −$4M
QuarterFree cash flowYoY
Q2 2026-$4.4M-$231.4K
Q1 2026-$5M-$398.6K
Q4 2025-$3.7M+$1M
Q3 2025-$6.7M+$2.5M
Q1 2025-$4.6M+$628.8K
Q4 2024-$4.8M+$739.4K
Q3 2024-$9.1M-$3.5M
Q1 2024-$5.2M+$111.3K

ACTU has burned cash in almost every quarter: −$20M over the past year, against −$23M the year before.

ACTU Total Shares

Q2 2024: 2MQ3 2024: 11MQ1 2025: 19MQ2 2025: 20MQ3 2025: 21MQ4 2025: 21MQ1 2026: 24MQ2 2026: 24M
Q2 2024: 2MQ3 2024: 11MQ1 2025: 19MQ2 2025: 20MQ3 2025: 21MQ4 2025: 21MQ1 2026: 24MQ2 2026: 24M
PeriodChange %Net change
Quarterly+1.4%+335K shares
1 year+22%+4.2M shares

ACTU has 24M diluted shares, up 22% from a year ago.

ACTU Net Leverage

ACTU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ACTU Weekly Momentum

MetricValueStatus
RSI28.8Oversold
Stochastic0.8Oversold

ACTU's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).

ACTU PE vs Healthcare Sector

ACTU has no meaningful PE right now: it lost money over the past year.

ACTU Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$0.5242% below
20 week MA$0.9669% below
50 week MA$2.6589% below
100 week MA$5.2594% below

ACTU is in a downtrend: it's below all four of its weekly moving averages, and 94% below its 100-week average.

ACTU Yearly ROI

YearStart priceEnd priceROI
2024$8.70$8.84+1.6%
2025$8.84$6.47-27%
2026 YTD$6.47$0.30-95%

ACTU has finished lower in one of the last two years. It's down 95% so far in 2026.

Give your agent the market.

Get API key